Article Text
PDF
Abstract
Background The number of patients using second-line antiretroviral therapy (ART) has increased over time. In Ethiopia, 1.5% of HIV infected patients on ART are using a second-line regimen and little is known about its effect in this setting.
Objective To estimate the rate and predictors of treatment failure on second-line ART among adults living with HIV in northwest Ethiopia.
Setting An institution-based retrospective follow-up study was conducted at three tertiary hospitals in northwest Ethiopia from March to May 2015.
Participants 356 adult patients participated and 198 (55.6%) were males. Individuals who were on second-line ART for at least 6 months of treatment were included and the data were collected by reviewing their records.
Primary outcome measure The primary outcome was treatment failure defined as immunological failure, clinical failure, death, or lost to follow-up. To assess our outcome, we used the definitions of the WHO 2010 guideline.
Result The mean±SD age of participants at switch was 36±8.9 years. The incidence rate of failure was 61.7/1000 person years. The probability of failure at the end of 12 and 24 months were 5.6% and 13.6%, respectively. Out of 67 total failures, 42 (62.7%) occurred in the first 2 years. The significant predictors of failure were found to be: WHO clinical stage IV at switch (adjusted HR (AHR) 2.1, 95% CI 1.1 to 4.1); CD4 count <100 cells/mm3 at switch (AHR 2.0, 95% CI 1.2 to 3.5); and weight change (AHR 0.92, 95% CI 0.88 to 0.95).
Conclusions The rate of treatment failure was highest during the first 2 years of treatment. WHO clinical stage, CD4 count at switch, and change in weight were found to be predictors of treatment failure.
- EPIDEMIOLOGY
- INFECTIOUS DISEASES
- PUBLIC HEALTH
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
Footnotes
Contributors ATT conceived the idea and the research designed by ATT, MW and TA. ATT coordinated the process. ATT and TA analysed the data. ATT, MW, TA and KAA wrote the paper. All authors read and approved the final manuscript.
Funding The financial backing of this research was provided by the University of Gondar as a grant to its staff.
Competing interests None declared.
Ethics approval Ethical clearance was obtained from the Institutional Review Board of University of Gondar. A letter of support and a permission letter were obtained from the Amhara Regional State Health Bureau and the hospital's administration, respectively. Care was taken to keep all patient information confidential. Since we used secondary sources, informed consent was waived.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement All data supporting our findings will be shared on request.